BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38303441)

  • 1. A prognostic prediction model for ovarian cancer using a cross-modal view correlation discovery network.
    Wang H; Han X; Ren J; Cheng H; Li H; Li Y; Li X
    Math Biosci Eng; 2024 Jan; 21(1):736-764. PubMed ID: 38303441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MMDAE-HGSOC: A novel method for high-grade serous ovarian cancer molecular subtypes classification based on multi-modal deep autoencoder.
    Wang HQ; Li HL; Han JL; Feng ZP; Deng HX; Han X
    Comput Biol Chem; 2023 Aug; 105():107906. PubMed ID: 37336028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Min-redundancy and max-relevance multi-view feature selection for predicting ovarian cancer survival using multi-omics data.
    El-Manzalawy Y; Hsieh TY; Shivakumar M; Kim D; Honavar V
    BMC Med Genomics; 2018 Sep; 11(Suppl 3):71. PubMed ID: 30255801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating multi-omics data by learning modality invariant representations for improved prediction of overall survival of cancer.
    Tong L; Wu H; Wang MD
    Methods; 2021 May; 189():74-85. PubMed ID: 32763377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classifying Breast Cancer Subtypes Using Deep Neural Networks Based on Multi-Omics Data.
    Lin Y; Zhang W; Cao H; Li G; Du W
    Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32759821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incorporating inter-relationships between different levels of genomic data into cancer clinical outcome prediction.
    Kim D; Shin H; Sohn KA; Verma A; Ritchie MD; Kim JH
    Methods; 2014 Jun; 67(3):344-53. PubMed ID: 24561168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knowledge boosting: a graph-based integration approach with multi-omics data and genomic knowledge for cancer clinical outcome prediction.
    Kim D; Joung JG; Sohn KA; Shin H; Park YR; Ritchie MD; Kim JH
    J Am Med Inform Assoc; 2015 Jan; 22(1):109-20. PubMed ID: 25002459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep learning based feature-level integration of multi-omics data for breast cancer patients survival analysis.
    Tong L; Mitchel J; Chatlin K; Wang MD
    BMC Med Inform Decis Mak; 2020 Sep; 20(1):225. PubMed ID: 32933515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-omics facilitated variable selection in Cox-regression model for cancer prognosis prediction.
    Liu C; Wang X; Genchev GZ; Lu H
    Methods; 2017 Jul; 124():100-107. PubMed ID: 28627406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local augmented graph neural network for multi-omics cancer prognosis prediction and analysis.
    Zhang Y; Xiong S; Wang Z; Liu Y; Luo H; Li B; Zou Q
    Methods; 2023 May; 213():1-9. PubMed ID: 36933628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated multi-omics analysis of ovarian cancer using variational autoencoders.
    Hira MT; Razzaque MA; Angione C; Scrivens J; Sawan S; Sarker M
    Sci Rep; 2021 Mar; 11(1):6265. PubMed ID: 33737557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the clinical utility of multi-omics data for predicting serous ovarian cancer prognosis.
    Zhang Z; Wei Z; Zhao L; Gu C; Meng Y
    J Obstet Gynaecol; 2023 Dec; 43(1):2171778. PubMed ID: 36803381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated multi-omics analysis of genomics, epigenomics, and transcriptomics in ovarian carcinoma.
    Zheng M; Hu Y; Gou R; Wang J; Nie X; Li X; Liu Q; Liu J; Lin B
    Aging (Albany NY); 2019 Jun; 11(12):4198-4215. PubMed ID: 31257224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Subtyping of Cancer Based on Robust Graph Neural Network and Multi-Omics Data Integration.
    Yin C; Cao Y; Sun P; Zhang H; Li Z; Xu Y; Sun H
    Front Genet; 2022; 13():884028. PubMed ID: 35646077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel prognostic model based on multi-omics features predicts the prognosis of colon cancer patients.
    Yang H; Jin W; Liu H; Wang X; Wu J; Gan D; Cui C; Han Y; Han C; Wang Z
    Mol Genet Genomic Med; 2020 Jul; 8(7):e1255. PubMed ID: 32396280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of histopathological images and multi-dimensional omics analyses predicts molecular features and prognosis in high-grade serous ovarian cancer.
    Zeng H; Chen L; Zhang M; Luo Y; Ma X
    Gynecol Oncol; 2021 Oct; 163(1):171-180. PubMed ID: 34275655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep multi-modal fusion network with gated unit for breast cancer survival prediction.
    Yuan H; Xu H
    Comput Methods Biomech Biomed Engin; 2024 May; 27(7):883-896. PubMed ID: 37166185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting censored survival data based on the interactions between meta-dimensional omics data in breast cancer.
    Kim D; Li R; Dudek SM; Ritchie MD
    J Biomed Inform; 2015 Aug; 56():220-8. PubMed ID: 26048077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using knowledge-driven genomic interactions for multi-omics data analysis: metadimensional models for predicting clinical outcomes in ovarian carcinoma.
    Kim D; Li R; Lucas A; Verma SS; Dudek SM; Ritchie MD
    J Am Med Inform Assoc; 2017 May; 24(3):577-587. PubMed ID: 28040685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multi-omics data simulator for complex disease studies and its application to evaluate multi-omics data analysis methods for disease classification.
    Chung RH; Kang CY
    Gigascience; 2019 May; 8(5):. PubMed ID: 31029063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.